Release of doxorubicin in sweat:: first step to induce the palmarplantar erythrodysesthesia syndrome?

被引：98

作者：

Jacobi, U ^{[1
]}

Waibler, E

Schulze, P

Sehouli, J

Oskay-Özcelik, G

Schmook, T

Sterry, W

Lademann, J

机构：

[1] Fac Med Charite, Dept Dermatol, Berlin, Germany

[2] Fac Med Charite, Dept Gynecol & Obstet, Berlin, Germany

来源：

ANNALS OF ONCOLOGY | 2005年 / 16卷 / 07期

关键词：

D O I：

10.1093/annonc/mdi204

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1210 / 1211

页数：2

共 5 条

[1] The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin [J].

Berry, G ;

Billingham, M ;

Alderman, E ;

Richardson, P ;

Torti, F ;

Lum, B ;

Patek, A ;

Martin, FJ .

ANNALS OF ONCOLOGY, 1998, 9 (07) :711-716

[2] Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer [J].

Charrois, GJR ;

Allen, TM .

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2004, 1663 (1-2) :167-177

[3] In vivo determination of doxorubicin and its metabolites within the skin using laser scanning microscopy [J].

Jacobi, U ;

Waibler, E ;

Bartoll, J ;

Schulze, P ;

Sterry, W ;

Lademann, J .

LASER PHYSICS LETTERS, 2004, 1 (02) :100-103

[4] Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin [J].

Lotem, M ;

Hubert, A ;

Lyass, O ;

Goldenhersh, MA ;

Ingber, A ;

Peretz, T ;

Gabizon, A .

ARCHIVES OF DERMATOLOGY, 2000, 136 (12) :1475-1480

[5]

SATO K, 1987, AM J PHYSIOL, V252, P166

← 1 →